搜索临床试验以:MPC-SHRC
总计1605个结果
-
Molecular Insight Pharmaceuticals, Inc.批准上市
-
Washington University School of MedicineBristol-Myers Squibb; Exelixis主动,不招人
-
University of Saskatchewan撤销
-
Emory UniversityGrady Health System完全的
-
Papworth Hospital NHS Foundation TrustLondon School of Hygiene and Tropical Medicine; King's College London; University of Sheffield; National...完全的
-
Procter and Gamble完全的
-
Jiangsu Renocell Biotech CompanyThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School招聘中
-
Guangdong Association of Clinical Trials尚未招聘
-
McGill University Health Centre/Research Institute...ASGE完全的
-
Stempeutics Research Pvt LtdStempeutics Research Malaysia SDN BHD撤销
-
Molecular Insight Pharmaceuticals, Inc.未知
-
Icahn School of Medicine at Mount SinaiBeth Israel Medical Center终止
-
Institut de Recherche pour le DeveloppementEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); ANRS... 和其他合作者完全的
-
Duke UniversityNational Institute of Mental Health (NIMH)完全的
-
Stempeutics Research Pvt LtdStempeutics Research Malaysia SDN BHD完全的
-
Hospital Universitari Son DuretaLaboratorios BIOMED SA未知
-
University of UtahSheila B. Terry Memorial Research Fund终止
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Alkermes, Inc.完全的
-
Merck Sharp & Dohme LLC招聘中膀胱肿瘤美国, 澳大利亚, 捷克语, 爱沙尼亚, 法国, 危地马拉, 匈牙利, 以色列, 意大利, 日本, 大韩民国, 马来西亚, 荷兰, 波兰, 葡萄牙, 波多黎各, 罗马尼亚, 西班牙, 台湾, 火鸡, 乌克兰, 英国, 丹麦, 拉脱维亚, 智利
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)招聘中II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 乳腺癌美国
-
Astellas Pharma Inc终止未接受过 EGFR-TKI 治疗且携带 EGFR 激活突变的 NSCLC 患者日本